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1. Introduction 
Phospholipid methylation has been implicated in 
the transduction through plasma membranes of a 
variety of receptor-mediated signals [1 ], including 
activation of adenylate cyclase by isoprenaline [2,3], 
lectin-induced formation of arachidonic acid, Ca 2÷- 
influx and mitogenesis [4,5], antigen-stimulated 
histamine release [4,6], and response to chemoattrac- 
trants [1,7]. Transmethylation s one of the 2 path- 
ways for the formation of phosphatidylcholine, pro- 
ceeding by successive steps of enzymatic transfer of 
methyl-groups to phosphatidylethanolarnine from the 
donor S-adenosylmethionine (AdoMet), to yield the 
final product via mono- and di-methylated interme- 
diates [8-11 ]. The evidence for the hypothesis that 
this transmethylation s involved in linking receptor 
signals to cellular esponses i  derived from experi- 
ments howing that phospholipid methylation led to 
increased membrane fluidity [12], that the various 
kinds of cell activation were associated with methyla- 
tion of phosphatidylethanolamine [1-6], and that 
some of these processes could be blocked by the use 
of methyltransferase inhibitors [4-6,13]. Still the 
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causal relationship between these phenomena may be 
questioned [ 14,15]. 
In the case of adenylate cyclase and phospholipid 
methylation, conflicting results exist. Data from retic- 
ulocytes may indicate that interaction between the 
/3-adrenergic receptor and the agonist promotes 
receptor-adenylate cyclase coupling via phospholipid 
transmethylation [2]. In contrast, results from liver 
indicate no effect of AdoMet-induced phospholipid 
methylation on adenylate cyclase [16], while the 
existence of cyclic AMP-dependent phospholipid 
methyltransferase in rat liver microsomes has been 
reported [ 17]. Furthermore, in lymphocytes trans- 
methylation i hibitors were found to enhance, rather 
than diminish, cyclic AMP responses to a variety of 
agents [18]. 
We show here that in isolated hepatocytes the 
phospholipid transmethylation can be inhibited 
almost completely (>95%), by pretreatment with 
c3Ado and Hcy, without any impairment ofthe cyclic 
AMP response to glucagon, adrenaline or isoprenaline. 
These results indicate that neither an increase nor a 
sustained high rate of phospholipid methylation is 
essential for the full responsiveness of the adenylate 
cyclase to glucagon or/3-adrenergic agents. 
2. Experimental 
L- [methyl)H] Methionine (75 Ci/mmol) was from 
the Radiochemical Centre, Amersham. Other chemi- 
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cals and radioisotopes were from the sources in 
[19-21]. 
Male Wistar rats (,-,200 g) fed ad libitum were 
used. In some animals 70% hepatectomy [22] was 
done to induce liver regeneration. Hepatocytes were 
isolated by either of 2 modifications [ 19,23 ] of an 
in vitro collagenase perfusion technique [24]. 
The hepatocytes were suspended in Krebs-Ringer 
solution with 25 mM Hepes (pH 7.4), containing 
10 mM glucose and 1% bovine serum albumin [25]. 
Incubations were performed using 0.8-2.0 ml cell 
suspension (1-5 × 106 cells/ml), under continuous 
shaking at 37°C. During a preincubation period of 
40 min some of the incubates were exposed to the 
following agents, singly or in combination: c3Ado, 
Hcy, and 50/aM unlabelled 1-methionine ofL-[methyl- 
aH]methionine (62.5 mCi/mmol). Other additons and 
length of subsequent incubations were as indicated. 
Unless otherwise specified, the incubations were termi- 
nated by quickly spinning the cells down (1000 × g, 
20 s) before homogenizing them in the appropriate 
extraction solutions for further analyses (see below). 
2.1. Determination f[ 3H] methyl incorporation i to 
phospholipids, and identification of radioactive 
phospholipids 
Pellets from cell suspensions that had been exposed 
to [methyl-all] methionine were homogenized in 
1.2 M HCI, collected on glass-fiber filters, and washed 
and extracted as in [21 ] for determination f total 
phospholipid radioactivity. The butanol extract was 
analyzed by thin-layer chromatography [21 ], and 
>90% of the radioactive material chromatographed as 
phosphatidylcholine/lysophosphatidylcholine. 
2.2. Determination f cellular content of AdoMet, 
AdoHcy and c3AdoHcy 
Cell pellets containing 2-3  X 106 hepatocytes were 
extracted with 5% sulfosalicylic acid. The extracts 
were analyzed by high-pressure liquid chromatography 
on a Partisil SCX column, eluted isocratically, using 
200-600 mM ammonium formate (pH 3-4) as the 
mobile phase. 
2.3. Assay of cyclic AMP and adenylate cyclase 
Pellets from the incubates (or in some cases full 
cell suspensions) were homogenized in either 0.3 M 
trichloroacetic a id or 0.6 M perchloric acid. The 
trichloroacetic a id extracts were neutralized with 
CaCOa [26], and acetylated and assayed for cyclic 
AMP by radioimmunoassay [27]. The extracts in per- 
chloric acid were mixed with a half volume of 1.08 M 
KOH/0.9 M KHCOa, centrifuged and analyzed by a 
protein binding assay [28]. Adenylate cyclase activity 
was measured in lysates of hepatocytes a in [29], 
using 0.2 mM [a-32p]ATP and Dowex 50/alumina 
double columns. 
3. Results 
3.1. Perturbation of phospholipid methylation 
caAdo perturbs various transmethylation reactions 
in the intact cells, by increasing the cellular content 
of the endogeneous inhibitor, AdoHcy, and by serving 
as a metabolic precursor for the Ado-Hcy analogue, 
caAdoHcy [30]. The supply of exogeneous Hcy fur- 
ther enhances the accumulation fAdoHcy (see below). 
Treatment ofhepatocytes with 0.3 mM caAdo reduced 
the rate of phospholipid methylation by ,--97%. The 
inhibition was also observed in the presence of gluca- 
gon, with or without MIX (fig.l). caAdo increased 
(by ~70%) the specific activity of AdoMet (not 
shown). No significant effect of glucagon on the 
uninhibited (i.e., no c3Ado) rate of incorporation of 
[aH] methyl groups into phospholipids was noted in 
our experiments (fig.l). The ratio AdoMet/PuoHcy 
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Fig.1. Phospholipid methylation i  rat hepatocytes. Left: 
incorporation f [all]methyl-groups from [3H]methionine 
into phospholipids of hepatocytes incubated for 40 min 
with radioactive methionine in the absence and presence of
caAdo (0.3 mM). At this time point, portions of the cell sus- 
pension were supplemented with glucagon (0.1 ;zM), glucagon 
plus MIX (0.5 mM) or no addition (control), and further 
incubated with these agents. The total incubation time is shown 
on the flgure. Right: time course of phospholipid methylation 
in the absence (control) and presence ofglucagon (0.1 pM). 
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Table 1 
Effect of precursors for transmethylation inhibitors on 
hepatocyte S-adenosylmethionine (pmol/10 ~ cells) and 
methylation i dex (M/) 
Addition 
during 
preincubation 
AdoMet AdoHcy c3AdoHcy MI 
No inhibitor 390 68 - 6 
3.3. Influence of methyltransferase inhibitors on the 
cyclic AMP accumulation and adenylate cyclase 
activation induced by glucagon and ~-adrenergic 
agents 
Preincubation of hepatocytes with caAdo, or c a Ado 
plus Hcy, did not reduce the cyclic AMP response to 
glucagon (fig.2,3). The time course of the cyclic AMP 
accumulation (fig.2) showed that at early stages no 
3-Deazaadenosine 
(0.3mM) 860 590 1200 0.5 
3-Deazaadenosine + 
D,L-homocysteine 
(0.35 raM) 770 750 2200 0.25 
Incubation time was 40 min. MI = S-adenosylmethionine/ 
total purine derivatives ofhomocysteine 
(i.e., the ratio between AdoMet and aU purine nucleo- 
side analogues of Hcy), termed methylation i dex 
(M/), has been stated to reflect he transmethylating 
capacity of the cell [30,31]. The cellular content of 
AdoMet and AdoHcy in the untreated hepatocytes 
was ~390 and 70 pmol/106 ceUs, respectively, corre- 
sponding to MI ~ 6. Preincubation of the cells with 
0.3 mM caAdo for 40 min led to a massive accumula- 
tion of AdoHcy and caAdoHcy, and only a moderate 
increase of AdoMet, with M/dropping to ,--0.5 
(table l). A further decrease (to 0.25) was observed 
when caAdo was combined with 0.5 mM Hcy. Pro- 
longed incubation led to even lower MI-values (not 
shown). Although these data indicate that Hcy 
decreases further the methylating capacity of caAdo -
treated cells, and might enhance the pronounced 
inhibition of phospholipid methylation that caAdo 
exerts when administered alone (rigA), measurements 
of the methylated phospholipids after combination of 
the 2 inhibitors were not carried out because Hey may 
affect the disposition of extraceUular [aH]methionine. 
3.2. Influence of methyltransferase inhibitors on 
hepatocyte cyclic AMP levels 
Hepatocytes xposed for 40 min to caAdo, alone 
or in combination with Hcy, showed significantly 
elevated levels of cyclic AMP (25 and 50% above 
basal, respectively). The attenuation of this effect 
when the phosphodiesterase inhibitor MIX was present 
(fig.2A) suggest that caAdo and Hcy increased the 
cyclic AMP level by inhibiting the breakdown rather 
than enhancing the synthesis. 
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Fig.2. Effect of methyltransferase inhibitors on the time 
course of cyclic AMP accumulation in rat hepatocytes. (A) 
The effect of MIX (0.5 raM): ( -o- )  control cells; ( -o- )  
cells preincubated (40 rain) with clAdo (0.3 raM); (- -~- -) 
cells preincubated with c3Ado +Hcy (0.35 raM). (B) The 
effect of glucagon (2 nM). Symbols as above. (C) The effect 
of glucagon +MIX. Concentrations and symbols as above. 
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Fig.3. Effect of methyltransferase inhibitors on the cyclic 
AMP content of hepatocytes incubated with varying concen- 
trations of glucagon. Untreated cells ( -o - )  and cells prein- 
cubated (40 rain) with 0.3 mM c3Ado ( -o - )  were incubated 
for 5 min with glucagon in the presence of 0.5 mM MIX. 
Inset shows the response to very low concentrations of glu- 
cagon. 
significant difference xisted between control cells 
and those treated with methyltransferase inhibitors, 
but increasing length of incubation with the hormone 
led to considerably enhanced accumulation i the 
caAdo/Hcy-treated cells, probably due to phospho- 
diesterase inhibition. 
Since in rat hepatocytes maximal cyclic AMP for- 
mation appears to require occupation of only a small 
fraction of the glucagon receptors [25], blockage of a 
phospholipid methylation-dependent r ceptor-cyclase 
coupling theoretically would lead to a right-shifted 
dose-response curve, without altering the maximal 
response. However, in cells incubated with hormone 
for 5 min (fig.3) or 90 s (not shown) no difference in 
dose-response curves for glucagon between control 
cells and hepatocytes treated with caAdo for 40 min 
was seen (fig.3). 
Because the hypothesis that phospholipid methyla- 
tion promotes receptor-cyclase coupling was based 
on studies with/3-adrenergic re eptor activation [ 1-3], 
the effects of adrenaline and isoprenaline were also 
examined. We used the observation that adrenergic 
responsiveness, which is normally very low in rat liver, 
increases during regeneration [32]. It was found that 
in hepatocytes isolated 48 h after 70% hepatectomy 
the strong response to adrenaline was not diminished 
by preincubation with methyltransferase inhibitors 
(table 2), and the initial time course or dose-response 
curve for cyclic AMP accumulation after isoprenaline 
(fig.4) were not altered. Again, in prolonged incuba- 
tions caAdo plus Hcy amplified the response to iso- 
prenaline. 
To exclude the possibility that a minor inhibition 
of cyclic AMP formation by transmethylation inhibi- 
tors might be masked by their inhibition of the break- 
down, hepatocytes (preincubated as described for the 
measurement of cyclic AMP accumulation) were 
quickly lysed and assayed for hormone-sensitive 
adenylate cyclase activity. No reduction i  the treated 
cells was found (table 3). 
Table 2 
Effect of methyltransferase inhibitors on hormone-induced accumulation of 
cyclic AMP (pmol/10 ~cells) in hepatocytes from regenerating rat liver 
Addition Basal Glucagon Adrenaline 
during (1.4 tzM) (50 IzM) 
preincubation 
No inhibitor 9.8 -+ 0.6 212.5 +- 18.9 180.8 ± 9.5 
3-Deazaadenosine 
(0.3 mM) 12.9 ± 3.1 203.0 ± 25.0 167.8 ± 20.5 
D,L-Homocysteine 
(0.35 mM) - 235.5 ± 29.1 194.5 ± 23.2 
3-Deazaadenosine + 
D,L-homocysteine - 227.8 ± 11.5 183.8 -+ 17.5 
Preincubation time with or without inhibitors was 40 min. The cells were exposed 
to hormones for 90 s in the presence of 0.5 mM MIX before the assay of cyclic 
AMP. The results are mean -+ SEM of 4 replicates 
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Fig.4. Effect of methyltransferase inhibitors on the cyclic 
AMP response of hepatocytes (from regenerating rat liver) to 
isoprenaline. (A) Time course of cyclic AMP accumulation 
induced by 50/~M isoprenaline: ( -o - )  control cells; ( - s - )  
cells preincubated (40 min) with caAdo (0.3 mM) +Hcy 
(0.35 mM). (B) Dose-response relationship for the cyclic 
AMP accumulation after 90 s exposure to varying concentra- 
tions of isoprenaline: ( -o - )  control cells; ( -e - )  cells prein- 
cubated (40 min) with caAdo (0.3 mM). MIX was present 
(0.5 mM) during all incubations after the pretreatment with 
methyltransferase inhibitors. 
Table 3 
Eft:ect of methyltransferase inhibitors on adenylate cyclase 
activity (pmol cyclic AMP. min -t . mg protein -]) in 
hepatocytes from regenerating rat liver 
Addition Basal Glucagon lsoprenaline 
during (14 uM) (50 ~M) 
preincubation 
No inhibitor 3.9 25.2 10.6 
3-Deazaadenosine 
(0.3 mM) 4.9 28.7 12.7 
3-Deazaadenosine + 
D,L-homocysteine 
(0.35 mM) 4.2 28.8 13.1 
Hepatocytes were preincubated with or without methyltrans- 
ferase inhibitors for 40 min. After quickly spinning the cells 
down, they were lysed and assayed for adenylate cyclase 
activity. The results are mean of 2 expt 
4. Discussion 
Here, inhibition of phospholipid methylation in 
isolated rat hepatocytes did not affect the time course 
or the dose--effect relationship for the cyclic AMP 
response to glucagon or fl-adrenergic agents. The results 
strongly disfavour the concept hat the transmethyla- 
tion is essential for receptor-adenylate cyclase 
coupling. Although the experimental conditions were 
not directly comparable, this is not in accordance 
with the data obtained in rat reticulocytes [2] which 
partly formed the basis for the hypothesis of the role 
of phospholipid methylation [1 ]. In those cells it 
was found that pretreatment with AdoMet increased 
isoprenaline-sensitive adenylate cyclase activity and 
that the stimulatory action of isoprenaline on phos- 
phatidylethanolamine m thylation [2] could not be 
mimicked by 8-Br-cyclic AMP, cholera toxin or NaF 
[2], indicating that the effect was exerted by t-recep- 
tors independently of cyclic AMP. These results are, 
however, compatible with experiments on rat liver 
membranes, where exposure to AdoMet, which 
enhanced the formation of methylated phospholipids, 
did not modify the basal, NaF-, GTP- or glucagon- 
sensitive adenylate cyclase activity [ 16]. Furthermore, 
the fact that in our experiments the stimulation of 
the cyclic AMP formation after fl-adrenergic agents as 
well as after glucagon was unaltered, despite almost 
complete inhibition of phospholipid methylation, 
indicated that at least in these cells transmethylation 
is not selectively required for the t-receptor-mediated 
activation of the adenylate cyclase. 
Phospholipid methylation has been reported to 
increase the number oft-receptors in reticulocytes 
[13]. Thus, although we found that the cyclic AMP 
response to isoprenaline was not diminished after 
incubation with transmethylation inhibitors for up 
to 70 min, the possibility that even longer pretreat- 
ment might have revealed impairment of the adrener- 
gic effect was not ruled out. Neither can we exclude 
the possibility that hepatocytes from regenerating 
liver, which have strongly enhanced adrenaline- 
responsive cyclic AMP formation [32] and increased 
number oft-receptors (unpublished), have become 
less dependent on transmethylation for the fl-adrenergic 
activation. Further studies are required to decide if 
phospholipid methylation might be involved in the 
increased adrenaline responsiveness of the hepatocyte 
adenylate cyclase that is observed in a variety of con- 
ditions [32-34].  
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The report that both glucagon and cyclic AMP 
increase the phospholipid methyltransferase activity 
(determined in broken cell preparations) of hepato- 
cytes [35] (although not confirmed under these con- 
ditions) provides upport for the concept [1 ] that 
hormones may stimulate phospholipid methylation, 
but indicate that this is secondary to, rather than a 
trigger of, the adenylate cyclase activation. 
The observation that c3Ado plus Hcy exerted long- 
term amplification of the cyclic AMP responses in the 
hepatocytes may support he data from lymphocytes 
[ 18] and oocytes [36] that agents that inhibit methyl- 
transferase can influence the cyclic AMP system by 
mechanisms not necessarily involving AdoMet-depen- 
dent phospholipid methylation. 
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